Pharmacy certification scheme undermined by fake logo

Phil Taylor

21-May-2010

PGEU certificate A rogue Internet pharmacy operating out of Russia has been found using a fake logo claiming it was accredited by the Pharmaceutical Group of the European Union (PGEU), illustrating the difficulties in policing the online trade in medicines.

It also raises questions about the value of mandating a community-wide logo for legitimate Internet pharmacy sites, as proposed by the European Parliament's ENVI committee in its amendments to the falsified medicines directive currently being developed in the EU.

The PGEU said today that a website selling medicines online - the Canadian Neighbor Pharmacy (www.cancarepharmacy.com) sported a PGEU certification logo and claimed that "all drugs sold ... are considered to be approved by PGEU."

The website - since taken down - also claimed certification by four other pharmacy bodies based in North America.

"By clicking on the ... logo at the bottom of the page, any potential customer would be redirected to a certificate 'issued' by PGEU," said the pharmacy group (see accompanying image).

PGEU maintains that the ease with which certification can itself be counterfeited exposes the limitations of such systems and shows that if they are to be implemented they need to be extremely robust.

The organisation's secretary general, John Chave, said: "Our experience shows that we run the risk of creating a false sense of security if counterfeiting certification is so easy."

"We should not put patients in the position of having to discriminate between fake and real certification", he continued, adding: "we need to explore technological options which put certification beyond the counterfeiters."

Related articles:

ENVI committee backs Matias report on falsified meds

Parliamentary report broadens, accelerates counterfeiting directive

PGEU wants robust debate on safety features

Interim EU measures needed to stem counterfeits

Features
Papers & Media
Research
Events

EC seeks comment on unique medicine identifiers
The European Commission has published a concept paper on the unique identifier for medicines, outlined in the EU falsified medicines directive and due to be fleshed out via the delegated acts process.
WHO working group drafts resolution on SSFFC medicines
Last week's meeting of a WHO working group on low quality and illegal drugs ended with a draft resolution for debate at the next World Health Assembly.
FDA finalises guidance for on-dose anti-counterfeit technologies
The US FDA has published its final guidance on the use of on-dose anti-counterfeiting technologies - referred to as physicochemical identifiers or PCIDs - for use in solid oral dosage forms such as tablets and capsules.
Pangea IV nets illegal medicines worth around $6.3m
The latest Interpol-backed offensive against illegal medicines has led to 55 arrests and seizures of 2.4m potentially harmful drugs worth around $6.3m.
FDA report models counterfeiting and diversion patterns in US
A new report form the US Food and Drug Administration (FDA) has used historical cases of medicine counterfeiting and diversion to gain a better understanding of the methods used by criminals and help prevent incidents in future.